The opinions expressed by Entrepreneur contributors are their own.
You are reading Entrepreneur India, the international franchise of Entrepreneur Media.
Life sciences companies working on therapies and technologies to cure disease and improve our quality of life require significant innovation, talent and upfront investment. From drug discovery through clinical testing to eventual regulatory approval and commercialization, it can take years for a product to generate revenue. In today’s downturn, an industry leader says the industry offers unique opportunities for growth. If they invest in the right technology and team. “This is a typical long-term growth sector,” Kavas commented. “Several factors will continue to have a positive impact on the industry, aging populations, increased awareness and wealth effects are increasing healthcare spending, obesity and metabolic disorders, to name a few”. Kavas added.
innovators and inventors Lin Kavas is Managing General Partner of Propel Bio Partners, a life science investment firm driving its strategy with scientific and business expertise. In this role, she is in a prime position to track the latest frontier developments in the industry, welcome new product developments and identify important changes in the market.
Kawas’ firm focuses primarily on small to mid-sized public companies and early stage private companies, which are expected to have the greatest growth potential. As co-founder and CEO of her previous companies through IPOs, Kawas uses her expertise and insight to identify opportunities to thrive even under economic stress. There are many unmet needs in patient care and the need for innovative therapies continues and will not change regardless of the economic environment.
“My mission is to support life sciences entrepreneurs and effect change in our industry, where clinical trials are conducted with a scientific lens and a patient-centric philosophy at all stages of product discovery and development,” said the company Patient-centric Kawas said.Operations is Kawas’ great concern and in Scaling podcasts by design“One of the things we look for is innovation in the organization, corporate structure that includes intentional hiring and lean business models” This is a model that the technology industry has leveraged, and now pioneers in the life sciences industry are applying some of these strategies and are leveraging strategic outsourcing Model. “You need to have a good understanding of your business and technology to successfully design network company structures and outsourcing models” As Kawas writes in her Forbes.
The potential benefits of a major investment in the life sciences industry are clear, says an industry group in California recently discovered The sector has helped create more than 400,000 jobs statewide, with a $376 billion positive economic impact.
Securing dedicated investment in the life sciences industry has significant public benefits. New medicines and technologies to overcome chronic health conditions have the potential to greatly ease the lives of patients and reduce the burden on their loved ones and society.
“Altruism is often as important as being wealthy in why someone decides to invest in the life sciences,” Kavas said. “We invest methodically — if we invest in companies with successful products and capable teams — the financial returns will follow.”
Perhaps, no other industry has a near-infinite future. More investment will lead to new breakthroughs, which in turn will help develop marketed products for existing diseases and medical problems, ranging from common diseases to undiscovered diseases. “As humans continue to evolve, there will always be a life sciences sector that investors should pay attention to,” Kavas said.
